Recent Acquisitions in this Sector
Embedded Files
Recent acquisitions show strong market interest and potential for high returns on investment.
About Edwards' Critical Care:
Core product: The gold-standard Swan-Ganz pulmonary artery catheters for monitoring Critical Care and HF patients
$928M total sales in 2023
7% yearly sales growth
About BD (NYSE: BDX):
One of the largest global medical technology companies in the world
$19.4B revenue in 2023
About Endotronix:
Product: Permanent electronic cardiac implant for monitoring chronic HF patients
$130M raised across 10 funding rounds from 12 investors, including strategic corporate partners Edwards and Medtronic
ROI 5.2x following FDA clearance in June 2024
About JenaValve:
Product: Specialized TAVR valve for patients with severe aortic regurgitation
$342M raised across 11 funding rounds from 21 investors
ROI 2.8x prior FDA clearance and without strategic corporate partner
About V-Wave:
Product: Interatrial shunt for chronic HF patients
$226M raised across 5 funding rounds from 13 investors, including strategic corporate partner Johnson & Johnson
ROI 7.5x following FDA clearance
About Shockwave Medical:
Product: Catheter-based medical devices to treat artery calcification
Nasdaq: SWAV
Page updated
Report abuse